These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 3523798)

  • 1. [Coexistence of implantation and autologous blastic crisis after bone marrow transplant in chronic myeloid leukemia].
    Ribera JM; Feliu E; Vives-Corrons JL; Marín P; Grañena A; Rozman C
    Sangre (Barc); 1986; 31(2):205-12. PubMed ID: 3523798
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of myeloid blastic crisis of chronic myelogenous leukemia.
    Preisler HD; Raza A; Higby D; Kirshner J; Woll J; Bennett J; Winton L; Weiner R; Richman C; Golomb H
    Cancer Treat Rep; 1984 Nov; 68(11):1351-5. PubMed ID: 6388833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Transplant of autologous bone marrow: indications and results].
    Bernasconi C; Alessandrino P
    Riv Emoter Immunoematol; 1985; 32(1):1-16. PubMed ID: 3909360
    [No Abstract]   [Full Text] [Related]  

  • 4. Use of peripheral blood stem cells for autologous transplantation in acute myeloid leukemia patients allows faster engraftment and equivalent disease-free survival compared with bone marrow cells.
    Visani G; Lemoli R; Tosi P; Martinelli G; Testoni N; Ricci P; Motta M; Gherlinzoni F; Leopardi G; Pastano R; Rizzi S; Piccaluga P; Isidori A; Tura S
    Bone Marrow Transplant; 1999 Sep; 24(5):467-72. PubMed ID: 10482929
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retrospective evaluation of autologous bone marrow transplantation vs allogeneic bone marrow transplantation from an HLA identical related donor in acute myelocytic leukemia. A study of the European Cooperative Group for Blood and Marrow Transplantation (EBMT).
    Gorin NC; Labopin M; Fouillard L; Meloni G; Frassoni F; Iriondo A; Brunet Mauri S; Goldstone AH; Harousseau JL; Reiffers J; Esperou-Bourdeau H; Gluckman E
    Bone Marrow Transplant; 1996 Jul; 18(1):111-7. PubMed ID: 8832003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High dose chemotherapy with busulfan, cyclophosphamide, and etoposide as conditioning regimen for allogeneic bone marrow transplantation for patients with acute myeloid leukemia in first complete remission.
    Zander AR; Berger C; Kröger N; Stockshläder M; Krüger W; Horstmann M; Grimm J; Zeller W; Kabisch H; Erttmann R; Schönrock P; Kuse R; Braumann D; Illiger HJ; Fiedler W; de Witt M; Hossfeld KD; Weh HJ
    Clin Cancer Res; 1997 Dec; 3(12 Pt 2):2671-5. PubMed ID: 10068272
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allogeneic bone marrow transplantation vs aggressive post-remission chemotherapy for children with acute myeloid leukemia in first complete remission. A prospective study from the French Society of Pediatric Hematology and Immunology (SHIP).
    Michel G; Leverger G; Leblanc T; Nelken B; Baruchel A; Landman-Parker J; Thuret I; Bergeron C; Bordigoni P; Esperou-Bourdeau H; Perel Y; Vannier JP; Schaison G
    Bone Marrow Transplant; 1996 Feb; 17(2):191-6. PubMed ID: 8640165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Near-tetraploid acute myeloid leukemia after allogeneic bone marrow transplantation.
    Laurenti L; d'Onofrio G; Zini G; Sica S; Chiusolo P; Leone G
    Haematologica; 2000 Apr; 85(4):432-4. PubMed ID: 10756374
    [No Abstract]   [Full Text] [Related]  

  • 9. Autologous marrow transplantation for patients with chronic myeloid leukemia in accelerated or blastic phase: report of 14 cases.
    Lemonnier MP; Gorin NC; Laporte JP; Douay L; Lopez M; van den Akker J; Stachowiak J; David R; Pene F; Kantor G
    Exp Hematol; 1986 Aug; 14(7):654-8. PubMed ID: 3525203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allogeneic bone marrow transplant in acute leukemias and chronic myeloid leukemia. Preliminary results from the BMT center of Pesaro.
    Izzi T; Polchi P; Galimberti M; Delfini C; Moretti L; Manna A; Porcellini A; Lucarelli G; Di Pietrantonj F
    Haematologica; 1984; 69(2):194-210. PubMed ID: 6429005
    [No Abstract]   [Full Text] [Related]  

  • 11. [Complete cytogenetic response obtained with unrelated donor lymphocyte infusion for relapse of chronic myeloid leukemia in blastic crisis after allogeneic bone marrow transplantation].
    Fujimaki K; Maruta A; Yoshida M; Yamazaki E; Matsuzaki M; Fujisawa S; Kanamori H; Ishigatsubo Y
    Rinsho Ketsueki; 2001 Mar; 42(3):204-8. PubMed ID: 11345783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dose-dependent effect of etoposide in combination with busulfan plus cyclophosphamide as conditioning for stem cell transplantation in patients with acute myeloid leukemia.
    Kröger N; Zabelina T; Sonnenberg S; Krüger W; Renges H; Stute N; Finkenstein F; Mayer U; Holstein K; Fiedler W; Colberg H; Sonnen R; Kuse R; Braumann D; Metzner B; del Valle F; Erttmann R; Kabisch H; Zander AR
    Bone Marrow Transplant; 2000 Oct; 26(7):711-6. PubMed ID: 11042650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Donor buffy-coat infusion and chemotherapy for leukemia in relapse after marrow transplantation.
    Bogdanić V; Aurer I; Hitrec V; Boban D; Nemet D; Zupancić-Salek S; Labar B
    Haematologica; 1995; 80(4):338-40. PubMed ID: 7590504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Severe esophageal stricture after autologous bone marrow transplant.
    Stemmelin GR; Pest P; Peters RA; Ceresetto JM; Shanley CM; Bullorsky EO
    Bone Marrow Transplant; 1995 Jun; 15(6):1001-2. PubMed ID: 7581074
    [No Abstract]   [Full Text] [Related]  

  • 15. Donor cell-derived acute myeloid leukemia developing 14 months after matched unrelated bone marrow transplantation for chronic myeloid leukemia.
    Hambach L; Eder M; Dammann E; Battmer K; Stucki A; Heil G; Ganser A; Hertenstein B
    Bone Marrow Transplant; 2001 Oct; 28(7):705-7. PubMed ID: 11704795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Bone marrow transplant in chronic myeloid leukemia].
    Fernańdez-Rañada JM; Vázquez L; Fernańdez-Garese D; Gómez Reino F; Solano C; González N; Lozano M; Fernández-Villalta MJ
    Sangre (Barc); 1984; 29(4-B):598-606. PubMed ID: 6393384
    [No Abstract]   [Full Text] [Related]  

  • 17. Favourable outcome for patients with myeloid disorders treated with fludarabine-melphalan reduced-intensity conditioning and allogeneic bone marrow stem cell transplantation without the use of T-lymphocyte-depleting antibodies.
    Malladi RK; Peniket AJ; Norton AE; Campbell AJ; Collins GP; Samol J; Eagleton H; Miller E; Morgenstern G; Jones J; Keen-Mcguire A; Barnardo M; Littlewood TJ
    Eur J Haematol; 2004 Aug; 73(2):85-92. PubMed ID: 15245506
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Partially mismatched related donor bone marrow transplantation as salvage for patients with AML who failed autologous stem cell transplant.
    Godder KT; Mehta J; Chiang KY; Adams S; van Rhee F; Singhal S; Higgins-Smith K; O'Neal W; DeRienzo S; Henslee-Downey JP
    Bone Marrow Transplant; 2001 Dec; 28(11):1031-6. PubMed ID: 11781612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone marrow transplantation in leukemia.
    Gale RP
    Ann Clin Res; 1981; 13(4-5):367-72. PubMed ID: 7039488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of blastic transformation of chronic granulocytic leukemia by chemotherapy, total body irradiation and infusion of cryopreserved autologous marrow.
    Buckner CD; Stewart P; Clift RA; Fefer A; Neiman PE; Singer J; Storb R; Thomas ED
    Exp Hematol; 1978 Jan; 6(1):96-109. PubMed ID: 342261
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.